Ocumension Therapeutics

FRA:5DG (China)   Ordinary Shares
€ 0.66 (0%) Mar 27
At Loss
P/B:
1.24
Market Cap:
€ 469.03M ($ 507.59M)
Enterprise V:
€ 352.47M ($ 381.45M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:

Business Description

Description
Ocumension Therapeutics is an ophthalmic pharmaceutical platform company identifying, developing, and commercializing ophthalmic therapies. It provides a pharmaceutical total solution to address unmet ophthalmic medical needs in China. Its product candidates include OT-401 (YUTIQ), OT-101, OT-301 (NCX 470), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-202, OT-503 (NCX 4251), OT-701, Ou Qin, Brimonidine tartrate eye drop, 0.5% moxifloxacin eye drop, OT-601-C, OT-302, OT-1301, T-1601, and OT-1602.
Name Current Vs Industry Vs History
Cash-To-Debt 7.61
Equity-to-Asset 0.89
Debt-to-Equity 0.05
Debt-to-EBITDA -0.4
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.31
Distress
Grey
Safe
Beneish M-Score -1.5
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 37.2
3-Year EPS without NRI Growth Rate 34.8
3-Year FCF Growth Rate -62.3
Name Current Vs Industry Vs History
5-Day RSI 37.51
9-Day RSI 49.78
14-Day RSI 53.3
6-1 Month Momentum % -32.95
12-1 Month Momentum % -43.81

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.82
Quick Ratio 3.72
Cash Ratio 3.33
Days Inventory 102.57
Days Sales Outstanding 151.6
Days Payable 522.12

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.2
Shareholder Yield % -0.43

Financials

FRA:5DG's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Ocumension Therapeutics Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 31.688
EPS (TTM) (€) -0.076
Beta 0.26
Volatility % 49.48
14-Day RSI 53.3
14-Day ATR (€) 0.016454
20-Day SMA (€) 0.6425
12-1 Month Momentum % -43.81
52-Week Range (€) 0.53 - 1.13
Shares Outstanding (Mil) 693.65

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Ocumension Therapeutics Filings

Filing Date Document Date Form
No Filing Data

Ocumension Therapeutics Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Ocumension Therapeutics Frequently Asked Questions

What is Ocumension Therapeutics(FRA:5DG)'s stock price today?
The current price of FRA:5DG is €0.66. The 52 week high of FRA:5DG is €1.13 and 52 week low is €0.53.
When is next earnings date of Ocumension Therapeutics(FRA:5DG)?
The next earnings date of Ocumension Therapeutics(FRA:5DG) is .
Does Ocumension Therapeutics(FRA:5DG) pay dividends? If so, how much?
Ocumension Therapeutics(FRA:5DG) does not pay dividend.

Press Release

Subject Date
No Press Release